Cambridge Healthtech Institute is pleased to announce the Fifth Annual ADAPT 2013: Accelerating Development & Advancing Personalized Therapy Congress is moving to Boston! ADAPT Congress brings together a unique and international mix of large and medium pharmaceutical, biotech and diagnostics companies, leading universities and clinical research institutions, government and national labs, CROs, emerging companies and tool providers -- making ADAPT Congress a perfect meeting-place to share experience, foster collaborations across industry and academia, and evaluate emerging technologies. The Congress also offers a balance of scientific sessions covering the latest research and strategic presentations and brainstorming sessions for the decision makers.
Conference Programs:
- Executive Summit: Global Strategies for Companion Diagnostics
- Clinical Biomarker Assay Development
- Exosomes and Microvesicles in Cancer
- Clinical and Translational Biomarkers
- Tumor Microenvironment